- Mebiopharm Co., Ltd.

	July 27, 2004	Attacking a cancer's source of nutrition: Applies to patent immunotherapeutic technique Nikkei Sangyo Shimbun
	July 19, 2004	Mebiopharm receives JETRO startup assistance in Silicon Valley -- first to move into the biotech industry Nikkan Kogyo Shimbun
	26 May, 2004	New cancer medicine delivered directly to diseased site Commercially available as early as 2007 in U.S. Nikkei Sangyo Shimbun, p. 1
	20 May, 2004	Universities that create wealth: new venture from The Tokyo University Nikkei Sangyo Shimbun
	May, 2004	New cancer drug developed that delivers medicine directly to diseased site Nikkei Net Advanced Medicine
	10 March, 2004	First Alliance Promotion -- message from Akamaru Venture Participation
P	March 2004	NIF Ventures Ltd. Nif news March edition